Tertiary lymphoid structures in esophageal cancer: a novel target for immunotherapy

被引：0

作者：

Zhai, Ke ^{[1
]}

Ma, Yuting ^{[2
]}

Gao, Xue ^{[2
]}

Ru, Kun ^{[1
]}

Zhao, Miaoqing ^{[2
]}

机构：

[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China

[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Pathol, Jinan, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷

基金：

中国国家自然科学基金;

关键词：

tertiary lymphoid structures; esophageal cancer; tumor microenvironment; immunotherapy; predictive biomarker; TUMOR MICROENVIRONMENT; TISSUE; CELLS;

D O I：

10.3389/fimmu.2025.1543322

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Esophageal cancer (EC), especially esophageal squamous cell carcinoma (ESCC), which is the most common subtype in China, is one of the most aggressive gastrointestinal malignancies. Traditional treatments like surgery, radiotherapy, and chemotherapy have limited success, but the study of tertiary lymphoid structure (TLS) has opened new avenues for immunotherapy. TLS is an ectopic immune cell cluster, including B cells, T cells, and dendritic cells (DCs), that forms in chronic inflammation such as tumors. TLS is often found at tumor invasion margins and is linked to better prognosis in EC patients, with higher TLS density and maturation associated with prolonged survival. TLS can also serve as a biomarker to assess immunotherapy outcomes. Further exploration of TLS molecular mechanisms could innovate EC treatments, especially by inducing TLS formation to improve therapy. This review summarizes the characteristics of TLS in EC, clinical findings, and the limitations and directions of current research, offering insights for future immunotherapy strategies.

引用

页数：18

共 101 条

[1] IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer [J].

Amisaki, Masataka ;

Zebboudj, Abderezak ;

Yano, Hiroshi ;

Zhang, Siqi Linsey ;

Payne, George ;

Chandra, Adrienne Kaya ;

Yu, Rebecca ;

Guasp, Pablo ;

Sethna, Zachary M. ;

Ohmoto, Akihiro ;

Rojas, Luis A. ;

Cheng, Charlotte ;

Waters, Theresa ;

Solovyov, Alexander ;

Martis, Stephen ;

Doane, Ashley S. ;

Reiche, Charlotte ;

Bruno, Emmanuel M. ;

Milighetti, Martina ;

Soares, Kevin ;

Odgerel, Zagaa ;

Moral, John Alec ;

Zhao, Julia N. ;

Gonen, Mithat ;

Gardner, Rui ;

Tumanov, Alexei V. ;

Khan, Abdul G. ;

Vergnolle, Olivia ;

Nyakatura, Elisabeth K. ;

Lorenz, Ivo C. ;

Baca, Manuel ;

Patterson, Erin ;

Greenbaum, Benjamin ;

Artis, David ;

Merghoub, Taha ;

Balachandran, Vinod P. .

NATURE, 2025, 638 (8052) :1076-1084

[2] Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers [J].

Baxter, Mark A. ;

Middleton, Fearghas ;

Cagney, Hannah P. ;

Petty, Russell D. .

BRITISH JOURNAL OF CANCER, 2021, 125 (08) :1068-1079

[3] High endothelial venules (HEVs) in immunity, inflammation and cancer [J].

Blanchard, Lucas ;

Girard, Jean-Philippe .

ANGIOGENESIS, 2021, 24 (04) :719-753

[4] Tertiary lymphoid structures improve immunotherapy and survival in melanoma [J].

Cabrita, Rita ;

Lauss, Martin ;

Sanna, Adriana ;

Donia, Marco ;

Larsen, Mathilde Skaarup ;

Mitra, Shamik ;

Johansson, Iva ;

Phung, Bengt ;

Harbst, Katja ;

Vallon-Christersson, Johan ;

van Schoiack, Alison ;

Loevgren, Kristina ;

Warren, Sarah ;

Jirstroem, Karin ;

Olsson, Hakan ;

Pietras, Kristian ;

Ingvar, Christian ;

Isaksson, Karolin ;

Schadendorf, Dirk ;

Schmidt, Henrik ;

Bastholt, Lars ;

Carneiro, Ana ;

Wargo, Jennifer A. ;

Svane, Inge Marie ;

Jonsson, Goran .

NATURE, 2020, 577 (7791) :561-+

[5] High infiltration of B cells in tertiary lymphoid structures, TCR oligoclonality, and neoantigens are part of esophageal squamous cell carcinoma microenvironment [J].

Carvalho Barros, Luciana Rodrigues ;

De Souza-Santos, Paulo Thiago ;

Marques Pretti, Marco Antonio ;

Vieira, Gustavo Fioravanti ;

De Souza Bragatte, Marcelo Alves ;

De Almeida Mendes, Marcus Fabiano ;

De Freitas, Martiela Vaz ;

Scherer, Nicole De Miranda ;

De Oliveira, Ivanir Martins ;

Mendes Rapozo, Davy Carlos ;

Fernandes, Priscila Valverde ;

Simao, Tatiana De Almeida ;

Soares-Lima, Sheila Coelho ;

Boroni, Mariana ;

Ribeiro Pinto, Luis Felipe ;

Bonamino, Martin Hernan .

JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 108 (04) :1307-1318

[6] TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures [J].

Chaurio, Ricardo A. ;

Anadon, Carmen M. ;

Costich, Tara Lee ;

Payne, Kyle K. ;

Biswas, Subir ;

Harro, Carly M. ;

Moran, Carlos ;

Ortiz, Antonio C. ;

Cortina, Carla ;

Rigolizzo, Kristen E. ;

Sprenger, Kimberly B. ;

Mine, Jessica A. ;

Innamarato, Patrick ;

Mandal, Gunjan ;

Powers, John J. ;

Martin, Alexandra ;

Wang, Zhitao ;

Mehta, Sumit ;

Perez, Bradford A. ;

Li, Roger ;

Robinson, John ;

Kroeger, Jodi L. ;

Curiel, Tyler J. ;

Yu, Xiaoqing ;

Rodriguez, Paulo C. ;

Conejo-Garcia, Jose R. .

IMMUNITY, 2022, 55 (01) :115-+

[7] STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment [J].

Chelvanambi, Manoj ;

Fecek, Ronald J. ;

Taylor, Jennifer L. ;

Storkus, Walter J. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)

[8] Cancer Statistics in China, 2015 [J].

Chen, Wanqing ;

Zheng, Rongshou ;

Baade, Peter D. ;

Zhang, Siwei ;

Zeng, Hongmei ;

Bray, Freddie ;

Jemal, Ahmedin ;

Yu, Xue Qin ;

He, Jie .

CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132

[9] Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial [J].

Chen, Yue-Yun ;

Wang, Pei-Pei ;

Hu, Yang ;

Yuan, Yong ;

Yang, Yu-Shang ;

Shi, Hua-Shan ;

Hao, Qing ;

Lin, Zhen ;

Tian, Jiang-Fang ;

Zheng, Yue ;

Liu, Ting ;

Lin, Pan-Pan ;

Xu, Heng ;

Ma, Xue-Lei ;

Yang, Li ;

Ding, Zhen-Yu .

BRITISH JOURNAL OF CANCER, 2024, 131 (07) :1126-1136

[10] Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response [J].

Chen, Ziqiang ;

Wang, Xiaobing ;

Jin, Zelin ;

Li, Bosen ;

Jiang, Dongxian ;

Wang, Yanqiu ;

Jiang, Mengping ;

Zhang, Dandan ;

Yuan, Pei ;

Zhao, Yahui ;

Feng, Feiyue ;

Lin, Yicheng ;

Jiang, Liping ;

Wang, Chenxi ;

Meng, Weida ;

Ye, Wenjing ;

Wang, Jie ;

Qiu, Wenqing ;

Liu, Houbao ;

Huang, Dan ;

Hou, Yingyong ;

Wang, Xuefei ;

Jiao, Yuchen ;

Ying, Jianming ;

Liu, Zhihua ;

Liu, Yun .

NPJ PRECISION ONCOLOGY, 2024, 8 (01)

← 1 2 3 4 5 6 7 8 9 10 →